Theo Crosson
Proteintech Group Europe, UK
Title: Fusion protein raised antibodies for evaluating mass spectrometry results
Biography
Biography: Theo Crosson
Abstract
Proteomics studies often rely on the use of antibodies. Their ability to bind any protein makes them powerful tools of use for quantification, detection, and characterisation of proteins. In particular, antibodies have been increasingly used in these past years for mass spectometry applications. Proteintech, founded by a group of scientists in 2002, is committed to manufacturing high quality antibodies in-house. Using whole-protein approach, longer time of immunization, and stringent validation procedures, Proteintech has been able to support research in proteomics. Its antibodies have been used for publications involving mass cytometry, IP-MS, and target evaluation from mass spectometry.